Similar Articles
Ajanta Launches Bioequivalent Generic Version of Singulair
An additional 19 of Ajanta's ANDAs are pending approval from the US FDA.
Mylan Launches Generics for Viramune XR, Glucotrol XL, Axert
Currently, Mylan has 253 ANDAs pending FDA approval representing $100.8 billion in annual brand sales, according to IMS Health